Cellular technologies in system of the intensive care of traumatic comas

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


The purpose of the present research is a studying of an opportunity to use cellular technologies in treatment of patients with traumatic comas. Cellular therapy was applied at 38 patients with a serious brain injury. All of them were at entering in clinic in coma I-III of a degree and had attributes of a vegetative condition formation on a background of stable vital functions. Suspension of unripe nervous and hemopoietic cells entered into a subarachnoid space through a spinal puncture. The control group consists of 38 patients and was comparable to group of research. Оutcomes of treatment were appreciated on Karnoffsky scale, Barthel ADL index and also on a scale of outcomes of Glasgow. Favorable (good and satisfactory) outcome of disease was marked at 33 (86,8 %) patients, receiving cellular therapy, and at 15 (39,5%) patients of control group. Good outcomes in control group were not. According to observation 1,5 years, the life quality of patients, receiving cellular therapy, authentically surpassed a similar control parameter. Complications of this method in the nearest and remote period were not registered. Received data specify possible expediency application of cellular therapy at patients with comas in the acute period of a serious brain injury.

Full Text

Restricted Access

About the authors

О. V. Parljuk

34 Munisipal Clinical Hospital, Novosibirsk

Author for correspondence.
Email: bozo.ilya@gmail.com
Russian Federation, Novosibirsk

V. I. Seledtsov

lmmanuel Kant State University of Russia

Email: bozo.ilya@gmail.com
Russian Federation, Kaliningrad

S. S. Rabinovich

Novosibirsk State Medical University

Email: bozo.ilya@gmail.com
Russian Federation, Novosibirsk

G. V. Seledtsova

Institute of Clinical Immunology, Russian Academy of Medical Sciences

Email: bozo.ilya@gmail.com
Russian Federation, Novosibirsk

S. V. Astrakov

34 Munisipal Clinical Hospital, Novosibirsk

Email: bozo.ilya@gmail.com
Russian Federation, Novosibirsk

V. I. Jarohno

34 Munisipal Clinical Hospital, Novosibirsk

Email: bozo.ilya@gmail.com
Russian Federation, Novosibirsk

V. A. Kozlov

Institute of Clinical Immunology, Russian Academy of Medical Sciences

Email: bozo.ilya@gmail.com
Russian Federation, Novosibirsk


  1. Seledtsov V.I., Avdeev I.V., Morenkov A.V. et al. Antiproliferative effect of bone marrow cells on leukemic cells. Immunobiology 1995; 192: 205-17.
  2. Teasdaile G., Jennet B. Assessment of coma and impaired consciousness. A practical Scale. Lancet 1974; 2: 81-4.
  3. Mahoney .I., Barthel D.W. Functional evaluation: the Barthel Index. Md. Med. J. 1965; 14: 61-5.
  4. Karnofsky D., Bucherval J. In the Clinical evolution of chemotherapeutic gents in cancer. Eds. C.M. Macleod. New York: Colombia University Press; 1949.
  5. Jennett B., Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1: 480.
  6. Брюховецкий В.А. Трансплантация нервных клеток и тканевая инженерия мозга при нервных болезнях. М.: ЗАО «Клиника восстановительной интервенционной неврологии и терапии «НейроВита»; 2003.
  7. Волошин П.В., Грищенко В.И., Черненков В.Г. и др. Предварительная оценка результатов метода трансплантации эмбриональных тканей в неврологии. Бюл. эксп. биол. мед. 1998; 126 (Прилож.1): 78-80.
  8. Семченко В.В., Еринеев С.И., Степанов С.С., Сергиенко Г.Г. Трансплантация незрелой нервной ткани в экспериментальной и клинической неврологии. Омск: ГУИПП Омский дом печати; 2000. 340.
  9. Шумаков В.И., Козин С.М., Брюховецкий А.С. Чехонин В.Н. Особенности раннего периода и осложнения при эндолюмбальной трансфузии клеток эмбриональной нервной ткани. Бюл. эксп. биол. мед. 1998; 126 (Прилож. 1): 72-7.
  10. Рабинович С.С., Селедцов В.И., Повещенко О.В. и др. Трансплантация стволовых кроветворных клеток в лечении спинномозговой травмы. Вестник Российской военно-медицинской академии 2003; 2: 121-6.
  11. Rabinovich S.S., Seledtsov V.I., Poveschenko O.V. et al. Transplantation treatment o spinal cord injury patients. Biomed. Pharmacother. 2003; 57: 428-33.
  12. Favcett J.W. Spinal cord repair: from experimental models to human application. Spinal Cord 1998; 36: 811-7.
  13. Гайдар Б.В., Брюховецкий А.С., Шумаков В.И. Результаты и перспективы применения трансплантации клеток нервной ткани человека при боевой травме мозга. Бюл. эксп. биол. мед. 1998; 126 (Прилож. 1): 133-4.
  14. Eglitis M.A., Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. PNAS USA 1997; 94: 4080-5.
  15. Seledtsov V.I., Taraban V.Y., Seledtsova G.V. et al. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative. Cellular Immunology 1997; 82: 12-9.
  16. Викторов И.В., Сухих Г.Т. Медико-биологические аспекты применения стволовых клеток. Вестник РАМН 2002; 4: 24-30.
  17. Моисеев А.Я., Самарин Д.М., Кустов С.М. и др. Опыт применения трансплантационной фетальной терапии в гинекологической практике при лечении рубцово-спаечных процессов. Бюл. эксп. биол. мед. 1998; 126 (Прилож. 1): 129-30.
  18. Murohara Т., Ikeda H., Duan J. et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 2000; l05: 1527-36.

Supplementary files

Supplementary Files
1. A.S. Bryukhovetsky

Download (37KB)

Copyright (c) 2008 Eco-Vector

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 85657 от 21.07.2023 от 11.03.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies